BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27009168)

  • 1. Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD.
    Rabinovich RA; Miller BE; Wrobel K; Ranjit K; Williams MC; Drost E; Edwards LD; Lomas DA; Rennard SI; Agustí A; Tal-Singer R; Vestbo J; Wouters EF; John M; van Beek EJ; Murchison JT; Bolton CE; MacNee W; Huang JT;
    Eur Respir J; 2016 May; 47(5):1365-73. PubMed ID: 27009168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease.
    McAllister DA; Maclay JD; Mills NL; Mair G; Miller J; Anderson D; Newby DE; Murchison JT; Macnee W
    Am J Respir Crit Care Med; 2007 Dec; 176(12):1208-14. PubMed ID: 17885263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between markers of emphysema and more severe chronic obstructive pulmonary disease.
    Boschetto P; Quintavalle S; Zeni E; Leprotti S; Potena A; Ballerin L; Papi A; Palladini G; Luisetti M; Annovazzi L; Iadarola P; De Rosa E; Fabbri LM; Mapp CE
    Thorax; 2006 Dec; 61(12):1037-42. PubMed ID: 16769715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortality.
    Williams MC; Murchison JT; Edwards LD; Agustí A; Bakke P; Calverley PM; Celli B; Coxson HO; Crim C; Lomas DA; Miller BE; Rennard S; Silverman EK; Tal-Singer R; Vestbo J; Wouters E; Yates JC; van Beek EJ; Newby DE; MacNee W;
    Thorax; 2014 Aug; 69(8):718-23. PubMed ID: 24473329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel CT-emphysema index/FEV
    Loh LC; Ong CK; Koo HJ; Lee SM; Lee JS; Oh YM; Seo JB; Lee SD
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2543-2550. PubMed ID: 30174423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic elastin degradation in chronic obstructive pulmonary disease.
    Maclay JD; McAllister DA; Rabinovich R; Haq I; Maxwell S; Hartland S; Connell M; Murchison JT; van Beek EJ; Gray RD; Mills NL; Macnee W
    Thorax; 2012 Jul; 67(7):606-12. PubMed ID: 22374923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers of extracellular matrix turnover are associated with emphysema and eosinophilic-bronchitis in COPD.
    Bihlet AR; Karsdal MA; Sand JM; Leeming DJ; Roberts M; White W; Bowler R
    Respir Res; 2017 Jan; 18(1):22. PubMed ID: 28103932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aerobic exercise training does not alter vascular structure and function in chronic obstructive pulmonary disease.
    Gelinas JC; Lewis NC; Harper MI; Melzer B; Agar G; Rolf JD; Eves ND
    Exp Physiol; 2017 Nov; 102(11):1548-1560. PubMed ID: 28857336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble Urokinase-Type Plasminogen Activator Receptor and Arterial Stiffness in Patients with COPD.
    Böcskei RM; Benczúr B; Losonczy G; Illyés M; Cziráki A; Müller V; Bohács A; Bikov A
    Lung; 2019 Apr; 197(2):189-197. PubMed ID: 30820636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical validity of plasma and urinary desmosine as biomarkers for chronic obstructive pulmonary disease.
    Huang JT; Chaudhuri R; Albarbarawi O; Barton A; Grierson C; Rauchhaus P; Weir CJ; Messow M; Stevens N; McSharry C; Feuerstein G; Mukhopadhyay S; Brady J; Palmer CN; Miller D; Thomson NC
    Thorax; 2012 Jun; 67(6):502-8. PubMed ID: 22250098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aortic Pulse Wave Velocity as a Measure of Cardiovascular Risk in Chronic Obstructive Pulmonary Disease: Two-Year Follow-Up Data from the ARCADE Study.
    Gale NS; Albarrati AM; Munnery MM; Mcdonnell BJ; Benson VS; Singer RMT; Cockcroft JR; Shale DJ
    Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 30987061
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased circulating desmosine and age-dependent elastinolysis in idiopathic pulmonary fibrosis.
    de Brouwer B; Drent M; van den Ouweland JMW; Wijnen PA; van Moorsel CHM; Bekers O; Grutters JC; White ES; Janssen R
    Respir Res; 2018 Mar; 19(1):45. PubMed ID: 29558926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary desmosine is associated with emphysema severity and frequent exacerbation in patients with COPD.
    Kim C; Ko Y; Kim SH; Yoo HJ; Lee JS; Rhee CK; Lee JH; Lee JH; Kim TH; Lim SY; Yoo KH; Seo JB; Oh YM; Lee SD; Park YB
    Respirology; 2018 Feb; 23(2):176-181. PubMed ID: 28905464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary desmosine excretion is inversely correlated with the extent of emphysema in patients with chronic obstructive pulmonary disease.
    Cocci F; Miniati M; Monti S; Cavarra E; Gambelli F; Battolla L; Lucattelli M; Lungarella G
    Int J Biochem Cell Biol; 2002 Jun; 34(6):594-604. PubMed ID: 11943590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic vascular dysfunction is associated with emphysema burden in mild COPD.
    Zelt JT; Jones JH; Hirai DM; King TJ; Berton DC; Pyke KE; O'Donnell DE; Neder JA
    Respir Med; 2018 Mar; 136():29-36. PubMed ID: 29501244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Spirometrically Confirmed Chronic Obstructive Pulmonary Disease on Arterial Stiffness and Surfactant Protein D After Percutaneous Coronary Intervention. The CATEPOC Study.
    Malik K; Diaz-Coto S; de la Asunción Villaverde M; Martinez-Camblor P; Navarro-Rolon A; Pujalte F; De la Sierra A; Almagro P
    Int J Chron Obstruct Pulmon Dis; 2022; 17():2577-2587. PubMed ID: 36267326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between plasma matrix metalloproteinase levels, pulmonary function, bronchodilator response, and emphysema severity.
    Koo HK; Hong Y; Lim MN; Yim JJ; Kim WJ
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1129-37. PubMed ID: 27313452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of secondhand smoke exposure on markers of elastin degradation.
    Slowik N; Ma S; He J; Lin YY; Soldin OP; Robbins RA; Turino GM
    Chest; 2011 Oct; 140(4):946-953. PubMed ID: 21415130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surrogate Markers of Cardiovascular Risk and Chronic Obstructive Pulmonary Disease: A Large Case-Controlled Study.
    Fisk M; McEniery CM; Gale N; Mäki-Petäjä K; Forman JR; Munnery M; Woodcock-Smith J; Cheriyan J; Mohan D; Fuld J; Tal-Singer R; Polkey MI; Cockcroft JR; Wilkinson IB;
    Hypertension; 2018 Mar; 71(3):499-506. PubMed ID: 29358458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term variability of desmosine/isodesmosine as biomarker in alpha-1-antritrypsin deficiency-related COPD.
    Fregonese L; Ferrari F; Fumagalli M; Luisetti M; Stolk J; Iadarola P
    COPD; 2011 Oct; 8(5):329-33. PubMed ID: 21793711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.